Bullish signal on daily chart
Meeting Agenda: Quarterly Results. Please add to watchlist to track closely.
Meeting Agenda: Quarterly Results. Please add to watchlist to track closely.
Company has spent 1.02% of its operating revenues towards interest expenses and 22.91% towards employee cost in the year ending Mar 31, 2020. (Source: Consolidated Financials)
50 day moving crossover appeared yesterday. Average price gain of 6.92% within 30 days of this signal in last 5 years.
Stock gave a 3 year return of 58.64% as compared to Nifty 100 which gave a return of 27.17%. (as of last trading session)
PE Ratio
This is a ratio arrived at by dividing the current market price of a stock by its latest (annual or annualized) earnings per share. Here we have taken the TTM (trailing twelve months) adjusted earnings per share.
EPS - TTM
Earnings per share (TTM) tells the profit after tax earned on a per share basis by a stock over the last twelve months or four quarters.
MCap
MCap or Market capitalization of a stock is calculated by multiplying the total number of shares outstanding of that particular stock with its current market price.
Sectoral MCap Rank
This is the ranking of a company within its sector based on MCap or Market capitalization. Higher the market capitalization of a company, higher the rank it is assigned.
PB Ratio
Price to Book represents the ratio of current market price of a stock to its book value per share. The book value itself is arrived at by dividing the net worth of a company by the total number of shares outstanding of the company at that time.
Dividend Yield
Dividend Yield calculates the amount of full year dividend declared by a company as a percentage of the current market price of a stock. All other things being equal, higher the dividend yield of the stock, the better it is for investors.
Face Value
Face value of a stock is the value ascribed to the stock as per the balance sheet of the company. The dividend declared by a company is usually declared as a percentage of face value.
Beta
1 Month | 0.87 |
3 Months | 1.37 |
6 Months | 0.95 |
1 Year | 0.98 |
3 Years | 1.08 |
VWAP
Volume Weighted Average Price represents the average price of a security over a particular time period (example one trading day) weighted by the volume traded at each price point.
52W H/L
This represents the 52 week high and low price of the security. It is also the 1 year high and low of the security. This represents the highest and lowest price touched by the security during the past 52 weeks or 1 year including today.
Share price of Biocon Ltd. rises as Nifty strengthens
NewsBiocon Ltd. shares fall 1.94% as Nifty drops
NewsStock market update: Nifty Pharma index slips 1%; Divi's Lab sheds 2%
NewsStatement Of Investor Complaints For The Quarter Ended December 2020
AnnouncementsAnnouncement under Regulation 30 (LODR)-Press Release / Media Release
AnnouncementsBUY
Buy Biocon, target price Rs 494: Yes Securities
RecosEmployee & Interest Expense
Company has spent 1.02% of its operating revenues towards interest expenses and 22.91% towards employee cost in the year ending Mar 31, 2020. (Source: Consolidated Financials)Quarterly | Annual | Sep 2020 | Jun 2020 | Mar 2020 | Dec 2019 | Sep 2019 |
---|---|---|---|---|---|
Total Income | 1,760.30 | 1,689.60 | 1,644.10 | 1,783.90 | 1,610.60 |
Total Income Growth (%) | 4.18 | 2.77 | -7.84 | 10.76 | 8.09 |
Total Expenses | 1,531.10 | 1,424.80 | 1,414.80 | 1,447.90 | 1,233.50 |
Total Expenses Growth (%) | 7.46 | 0.71 | -2.29 | 17.38 | 7.02 |
EBIT | 229.20 | 264.80 | 229.30 | 336.00 | 377.10 |
EBIT Growth (%) | -13.44 | 15.48 | -31.76 | -10.90 | 11.77 |
PAT | 169.30 | 149.40 | 123.40 | 202.80 | 215.70 |
PAT Growth (%) | 13.32 | 21.07 | -39.15 | -5.98 | 4.56 |
EBIT Margin (%) | 13.02 | 15.67 | 13.95 | 18.84 | 23.41 |
Net Profit Margin (%) | 9.62 | 8.84 | 7.51 | 11.37 | 13.39 |
Basic EPS (₹) | 1.43 | 1.26 | 1.04 | 1.71 | 1.82 |
All figures in Rs Cr, unless mentioned otherwise
Annual | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
---|---|---|---|---|---|
Total Assets | 14,443.80 | 12,192.40 | 9,989.70 | 9,394.20 | 8,458.10 |
Total Assets Growth (%) | 18.47 | 22.05 | 6.34 | 11.07 | 32.67 |
Total Liabilities | 7,060.70 | 5,485.50 | 4,341.20 | 4,180.40 | 4,158.50 |
Total Liabilities Growth (%) | 28.72 | 26.36 | 3.85 | 0.53 | 41.80 |
Total Equity | 7,383.10 | 6,706.90 | 5,648.50 | 5,213.80 | 4,299.60 |
Total Equity Growth (%) | 10.08 | 18.74 | 8.34 | 21.26 | 24.89 |
Current Ratio (x) | 1.33 | 1.61 | 1.94 | 2.41 | 2.38 |
Total Debt to Equity (x) | 0.28 | 0.29 | 0.37 | 0.46 | 0.61 |
Contingent Liabilities | 1,489.90 | 1,600.60 | 1,115.90 | 786.50 | 803.60 |
All figures in Rs Cr, unless mentioned otherwise
Increase in Cash from Investing
Company has used Rs 1558.9 cr for investing activities which is an YoY increase of 118.39%. (Source: Consolidated Financials)Annual | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
---|---|---|---|---|---|
Net Cash flow from Operating Activities | 1,283.10 | 1,154.60 | 662.10 | 640.00 | 370.60 |
Net Cash used in Investing Activities | -1,558.90 | -713.80 | -684.00 | -498.50 | -1,141.70 |
Net Cash flow from Financing Activities | 387.60 | -241.70 | -239.70 | -177.50 | 1,067.60 |
Net Cash Flow | 165.40 | 210.30 | -261.20 | -47.30 | 300.00 |
Closing Cash & Cash Equivalent | 824.70 | 659.30 | 449.00 | 710.20 | 757.50 |
Closing Cash & Cash Equivalent Growth (%) | 25.09 | 46.84 | -36.78 | -6.24 | 63.75 |
Total Debt/ CFO (x) | 1.47 | 1.55 | 2.90 | 3.45 | 6.66 |
All figures in Rs Cr, unless mentioned otherwise
Annual | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
---|---|---|---|---|---|
Return on Equity (%) | 11.15 | 14.84 | 7.18 | 12.65 | 13.64 |
Return on Capital Employed (%) | 11.61 | 11.91 | 8.28 | 11.13 | 8.80 |
Return on Assets (%) | 5.18 | 7.42 | 3.72 | 6.51 | 6.50 |
Interest Coverage Ratio (x) | 18.68 | 15.38 | 10.57 | 33.05 | 20.42 |
Asset Turnover Ratio (x) | 44.08 | 45.22 | 41.27 | 41.42 | 39.57 |
Price to Earnings (x) | 43.48 | 40.65 | 96.15 | 37.04 | 17.54 |
Price to Book (x) | 4.84 | 6.01 | 6.88 | 4.69 | 2.39 |
EV/EBITDA (x) | 19.29 | 24.70 | 35.47 | 21.30 | 12.79 |
EBITDA Margin (%) | 27.71 | 27.89 | 25.10 | 29.21 | 25.30 |
Bullish / Bearish signals for Biocon Ltd. basis selected technical indicators and moving average crossovers.
50 Day EMA Crossover
Bullish signal on daily chart
Appeared on: 19 Jan 2021
50D EMA: 451.11
Date | 30 days Gain/Loss % |
---|---|
26 Nov 2020 | 14.56% |
24 Nov 2020 | 2.41% |
12 Nov 2020 | 3.70% |
25 Sep 2020 | 11.68% |
Average price gain of 6.92% within 30 days of Bullish signal in last 5 years
MACD Crossover
Bearish signal on weekly chart
Appeared on: 15 Jan 2021
Region: Positive
Date | 7 weeks Gain/Loss % |
---|---|
23 Oct 2020 | -6.58% |
14 Aug 2020 | -5.78% |
20 Mar 2020 | -8.93% |
15 Feb 2019 | -1.83% |
Average price decline of -5.29% within 7 weeks of Bearish signal in last 10 years
5 Day EMA Crossover
Bearish signal on daily chart
Appeared on: 15 Jan 2021
5D EMA: 463.10
Date | 7 days Gain/Loss % |
---|---|
13 Jan 2021 | -0.92% |
6 Jan 2021 | -1.28% |
28 Dec 2020 | -2.69% |
21 Dec 2020 | -2.89% |
Average price decline of -2.63% within 7 days of Bearish signal in last 5 years
R1 | R2 | R3 | PIVOT | S1 | S2 | S3 | |
---|---|---|---|---|---|---|---|
Classic | 455.72 | 459.83 | 467.13 | 452.53 | 448.42 | 445.23 | 437.93 |
5 DAYS | 14 DAYS | 28 DAYS | |
---|---|---|---|
ATR | 12.04 | 12.75 | 13.15 |
Stock Returns vs Nifty 100
Stock gave a 3 year return of 58.64% as compared to Nifty 100 which gave a return of 27.17%. (as of last trading session)Stock Returns vs Nifty Pharma
Stock generated 58.64% return as compared to Nifty Pharma which gave investors 31.29% return over 3 year time period. (as of last trading session)Choose from Peers
Choose from Stocks
Stock Returns vs Nifty 100
Stock gave a 3 year return of 58.64% as compared to Nifty 100 which gave a return of 27.17%. (as of last trading session)Stock Returns vs Nifty Pharma
Stock generated 58.64% return as compared to Nifty Pharma which gave investors 31.29% return over 3 year time period. (as of last trading session)341.27
Amount Invested (in Cr.)
2.62%
% of AUM
0.27
% Change (MoM basis)
212.98
Amount Invested (in Cr.)
0.96%
% of AUM
-15.62
% Change (MoM basis)
196.74
Amount Invested (in Cr.)
0.69%
% of AUM
-9.00
% Change (MoM basis)
MF Ownership as on 31 December 2020
Price
453.153.85 (0.86%)
Open | High | Low | Prev Close | Contracts Traded | Turnover (₹ Lakhs) |
---|---|---|---|---|---|
452.00 | 456.85 | 450.20 | 449.30 | 1,459 | 15,226.24 |
Meeting Date | Announced on | Purpose | Details |
---|---|---|---|
Jan 21, 2021 | Jan 05, 2021 | Board Meeting | Quarterly Results |
Oct 22, 2020 | Oct 06, 2020 | Board Meeting | Quarterly Results |
Jul 24, 2020 | Jul 01, 2020 | AGM | - |
Jul 23, 2020 | Jul 07, 2020 | Board Meeting | Quarterly Results |
Jul 23, 2020 | Jul 01, 2020 | AGM | - |
Type | Dividend | Dividend per Share | Ex-Dividend Date | Announced on |
---|---|---|---|---|
Final | 10% | 0.5 | Jul 18, 2019 | Apr 25, 2019 |
Final | 20% | 1.0 | Jul 19, 2018 | Apr 26, 2018 |
Final | 20% | 1.0 | Jul 20, 2017 | May 02, 2017 |
Interim | 100% | 5.0 | Mar 17, 2016 | Mar 08, 2016 |
Interim | 100% | 5.0 | Apr 09, 2015 | Mar 27, 2015 |
All Types | Ex-Date | Record Date | Announced on | Details |
---|---|---|---|---|
Bonus | Jun 12, 2019 | Jun 13, 2019 | Apr 25, 2019 | Bonus Ratio: 1 share(s) for every 1 shares held |
Bonus | Jun 15, 2017 | Jun 17, 2017 | Apr 27, 2017 | Bonus Ratio: 2 share(s) for every 1 shares held |
Bonus | Sep 11, 2008 | Sep 12, 2008 | Apr 22, 2008 | Bonus Ratio: 1 share(s) for every 1 shares held |
Biocon Ltd., incorporated in the year 1978, is a Large Cap company (having a market cap of Rs 54192.00 Crore) operating in Pharmaceuticals sector. Biocon Ltd. key Products/Revenue Segments include Bio Pharmaceuticals which contributed Rs 1811.70 Crore to Sales Value (91.11 % of Total Sales), Other Operating Revenue which contributed Rs 157.50 Crore to Sales Value (7.92 % of Total Sales), Waste which contributed Rs 15.80 Crore to Sales Value (0.79 % of Total Sales) and Sale of services which contributed Rs 3.40 Crore to Sales Value (0.17 % of Total Sales)for the year ending 31-Mar-2020. Show More
A V Sriram
HeadAmitava Saha
Head - Human ResourceB S V Prasad
Chief Operating OfficerBobby Kanubhai Parikh
Independent DirectorIndustry
Key Indices Listed on
Nifty Next 50, Nifty 100, Nifty 200, + 25 more
Address
20th K.M. Hosur Road,Electronics City,Bengaluru, Karnataka - 560100
Biocon Ltd. share price moved up by 0.24% from its previous close of Rs 451.60. Biocon Ltd. stock last traded price is 452.70
Share Price | Value |
---|---|
Today/Current/Last | 452.70 |
Previous Day | 451.60 |
DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).
DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.
By using this site, you agree to the Terms of Service and Privacy Policy.